Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy

RECRUITINGN/ASponsored by Covenant Health, US

Actively Recruiting

PhaseN/A

SponsorCovenant Health, US

Started2025-06-10

Est. completion2026-03-31

Eligibility

Age60 Years – 90 Years

Healthy vol.Accepted

Locations6 sites

View on ClinicalTrials.gov →

NCT07222280

Summary

The goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease. * Will this blood test have the ability to distinguish between Alzheimer's disease and other causes of cognitive impairment in the inpatient setting? * Neurology Clinic will complete a 6-month post-hospitalization follow up with patients who have had the Quest AD-Detect Alzheimer's Disease blood test completed while they were inpatient to discuss the risk assessment portfolio

Eligibility

Age: 60 Years – 90 YearsHealthy volunteers accepted

Inclusion Criteria:

* Ages 60 to 90 years old
* No prior diagnosis of dementia
* Currently hospitalized with cognitive diagnosis, including but no limited to; delirium, encephalopathy, etc. thought to be secondary to a toxic/metabolic state

Exclusion Criteria:

* Age under 60 years
* Prior diagnosis of dementing illness or other organic etiology to cognitive impairment

Conditions6

Alzheimer DementiaAlzheimer DiseaseAlzheimer's DiseaseCognitive AbnormalityDelirium Confusional StateEncephalopathy